Peak Hours News
  • Investing
  • Stock
  • Economy
  • Editor’s Pick
Investing

US imposing new export controls on biotech equipment over China concerns

by January 15, 2025
written by January 15, 2025

By David Shepardson

WASHINGTON (Reuters) – The U.S. Commerce Department said Wednesday it is imposing new export controls on biotechnology equipment and related technology because of national security concerns tied to artificial intelligence and data science.

Washington has raised concerns that China could use U.S. technology to strengthen military capabilities and help design new weapons through AI. The department said the laboratory equipment could be used for “human performance enhancement, brain-machine interfaces, biologically-inspired synthetic materials, and possibly biological weapons.”

The new export controls, which restrict shipments to China and other countries without a U.S. license, are for high-parameter flow cytometers and certain mass spectrometry equipment, which Commerce said can “generate high-quality, high-content biological data, including that which is suitable for use to facilitate the development of AI and biological design tools.”

This is the latest effort by Washington to restrict U.S. technology to China. On Monday, Commerce moved to further restrict AI chip and technology exports from China aimed at helping the United States maintain its dominant status in AI by controlling it around the world.

U.S. lawmakers have been considering a number of proposals to keep Americans’ personal health and genetic information from foreign adversaries and aim to push U.S. pharmaceutical and biotech companies to lessen their reliance on China for everything from drug ingredient manufacturing to early research.

Last week, U.S. lawmakers called on the Commerce Department to consider restricting the export of U.S. biotechnology to the Chinese military, citing concerns Beijing could weaponize it.

The Chinese Embassy in Washington last week said Beijing “firmly opposes any country’s development, possession or use of biological weapons.”

In August, U.S. lawmakers called on the Food and Drug Administration to ramp up scrutiny of U.S. clinical trials conducted in China, citing the risk of intellectual property theft and the possibility of forced participation of members of China’s Uyghur minority group.

This post appeared first on investing.com

0 comment
0
FacebookTwitterPinterestEmail

previous post
Latest US sanctions on Russia more serious says Macquarie
next post
Trump’s new SEC leadership poised to kick start crypto overhaul, sources say

You may also like

How billionaire Caltagirone could influence Italy’s banking M&A...

July 6, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

July 5, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

July 4, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

July 3, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

July 2, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

July 1, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

June 30, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

June 29, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

June 28, 2025

How billionaire Caltagirone could influence Italy’s banking M&A...

June 27, 2025
Stay updated with the latest news, exclusive offers, and special promotions. Sign up now and be the first to know! As a member, you'll receive curated content, insider tips, and invitations to exclusive events. Don't miss out on being part of something special.









    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    Recent Posts

    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      July 6, 2025
    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      July 5, 2025
    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      July 4, 2025
    • Essence Fest leads a summer of events for Black entrepreneurs galvanized by economic uncertainty

      July 4, 2025
    • How billionaire Caltagirone could influence Italy’s banking M&A wave

      July 3, 2025

    Categories

    • Economy (506)
    • Editor's Pick (10)
    • Investing (911)
    • Stock (798)
    • About us
    • Contact us
    • Privacy Policy
    • Terms & Conditions

    Disclaimer: peakhoursnews.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Back To Top
    Peak Hours News
    • Investing
    • Stock
    • Economy
    • Editor’s Pick